Johnson & Johnson's Experimental Covid-19 Vaccine Protects Monkeys in a Single Dose-study
4 years, 4 months ago

Johnson & Johnson's Experimental Covid-19 Vaccine Protects Monkeys in a Single Dose-study

News 18  

Johnson & Johnson on Thursday kicked off US human safety trials for its COVID-19 vaccine after releasing details of a study in monkeys that showed its best-performing vaccine candidate offered strong protection in a single dose. J&J's vaccine uses a common cold virus known as adnovirus type 26 or Ad26 to ferry coronavirus proteins into cells in the body, causing the body to mount an immune defense against the virus. In the monkey study, scientists from J&J and Harvard's Beth Israel Deaconess Medical Center studied seven different potential vaccines in 32 animals and compared the results to 20 control animals who got placebo shots. In the best-performing candidate, which J&J selected for human testing, none of the animals had virus in their lungs and only one showed low levels of virus in nasal swabs. "This study shows that even just a single immunization with the Ad26 vaccine leads to neutralizing antibody responses and robust protection of monkeys against COVID-19," said Dr. Dan Barouch, a vaccine researcher at Beth Isreal Deaconness who led the research in collaboration with J&J.

Animals Virus Study Single Vaccine Nasal Swabs Stoffels  virus  second  johnsons  johnson  experimental  dosestudy  protects  animals  study  singleshot  single  covid19  testing  vaccine  monkeys  jj  showed

History of this topic

Inhaled vaccine to be more effective
2 years, 6 months ago

Inhaled vaccine to be more effective

The Hindu  

A multidisciplinary team from the McMaster University, Toronto is working to make inhaled vaccines a reality. Fiona Smaill, Professor of Pathology and Molecular Medicine, McMaster University, and a part of the multidisciplinary team, said that they are testing a next-generation COVID-19 vaccine that the earlier research in animals suggests will last longer, will be more effective and stand up well …

J&J Covid-19 vaccine ‘limited’ to some people after clot concerns: Report
2 years, 7 months ago

J&J Covid-19 vaccine ‘limited’ to some people after clot concerns: Report

Hindustan Times  

Johnson & Johnson’s Covid-19 vaccine was limited to use only in adults for whom other shots aren’t appropriate after an investigation of rare and potentially deadly clotting disorder that occurs in some recipients. J&J’s single-shot vaccine has been noted for its convenience compared to two-shot vaccines, especially in remote areas and in populations like the homeless who may be difficult …

FDA restricts Johnson & Johnson’s COVID-19 vaccine due to blood clot risk
2 years, 7 months ago

FDA restricts Johnson & Johnson’s COVID-19 vaccine due to blood clot risk

LA Times  

Vials of the Johnson & Johnson COVID-19 vaccine are seen at a pharmacy in 2021. U.S. regulators on Thursday strictly limited who can receive Johnson & Johnson’s COVID-19 vaccine due to the ongoing risk of rare but serious blood clots. FDA officials said in a statement that they decided to restrict J&J’s vaccine after taking another look at data on …

J&J vaccine recipients were FIVE TIMES as likely to be hospitalized with Covid as Pfizer recipients
2 years, 9 months ago

J&J vaccine recipients were FIVE TIMES as likely to be hospitalized with Covid as Pfizer recipients

Daily Mail  

The Johnson & Johnson COVID-19 vaccine was not nearly as effective as its peers at preventing hospitalization from the virus, a new study of elderly patients finds. A French research team found that 28 days after administration of the single-dose J&J shot, and the second dose of the Pfizer-BioNTech vaccine, the J&J recipients were 5.2 times more likely to be …

Over-50s set to be offered Covid booster vaccines this autumn
2 years, 10 months ago

Over-50s set to be offered Covid booster vaccines this autumn

The Telegraph  

Millions of over-50s could be offered Covid boosters this autumn, as Boris Johnson hailed Britain's vaccine rollout as key to "restoring our liberties in full". Fourth jabs will start being offered to those aged 75 and over from next month, with a further rollout of vaccines expected later this year, when the programme may be much more widely extended. Announcing …

Three doses of Pfizer Covid vaccine better than two: Study
2 years, 10 months ago

Three doses of Pfizer Covid vaccine better than two: Study

Deccan Chronicle  

Washington: A third dose of the Pfizer COVID-19 vaccine conferred higher effectiveness against infection and hospitalisation than two doses of the preventive after one month, a study has found. "When we looked at the effectiveness of the two doses of Pfizer–BioNTech vaccine versus three doses, we see a benefit with three doses that exceeds that achieved with two doses alone," …

Vaccine protection better maintained against severe COVID-19: Lancet study
2 years, 10 months ago

Vaccine protection better maintained against severe COVID-19: Lancet study

Firstpost  

The results showed that protection against infection of any severity waned progressively following the peak which occurred a month after the second dose London: The vaccine-induced protection against SARS-CoV-2 infection wanes within a few months, but protection against severe COVID-19 appears to be better maintained, according to a study published in The Lancet journal. “The bad news is that the …

Vaccine protection better maintained against severe Covid-19: Lancet study
2 years, 10 months ago

Vaccine protection better maintained against severe Covid-19: Lancet study

India Today  

The vaccine-induced protection against SARS-CoV-2 infection wanes within a few months, but protection against severe COVID-19 appears to be better maintained, according to a study published in The Lancet journal. "The bad news is that the protection against infection seems to be diminished by seven months after the second dose of vaccine," said Peter Nordstrom, a professor at Umea University …

Vaccine protection better maintained against severe COVID-19: Lancet study
2 years, 10 months ago

Vaccine protection better maintained against severe COVID-19: Lancet study

Deccan Chronicle  

London: The vaccine-induced protection against SARS-CoV-2 infection wanes within a few months, but protection against severe COVID-19 appears to be better maintained, according to a study published in The Lancet journal. "The bad news is that the protection against infection seems to be diminished by seven months after the second dose of vaccine," said Peter Nordstrom, a professor at Umea …

Booster shots needed against omicron, CDC studies show
2 years, 11 months ago

Booster shots needed against omicron, CDC studies show

Associated Press  

NEW YORK — Three studies released Friday offered more evidence that COVID-19 vaccines are standing up to the omicron variant, at least among people who received booster shots. The papers echo previous research — including studies in Germany, South Africa and the U.K. — indicating available vaccines are less effective against omicron than earlier versions of the coronavirus, but also …

COVID-19 vaccine booster provides effective antibody protection against Omicron, says Lancet study
2 years, 11 months ago

COVID-19 vaccine booster provides effective antibody protection against Omicron, says Lancet study

Firstpost  

COVID-19 Vaccine Booster | The study found that in people who had received the Pfizer vaccine for all three doses, antibody levels against Omicron after a third dose were similar to those previously reached against Delta after only two shots. London: A third dose of COVID-19 vaccine increases the level of antibodies that can effectively neutralise the Omicron variant of …

2 Vaccine Doses, Previous Infection May Protect Against Covid for a Year: Study
2 years, 11 months ago

2 Vaccine Doses, Previous Infection May Protect Against Covid for a Year: Study

News 18  

Many wonder how much of an impact the vaccine has had on the Covid-19. According to new research, a person who has previously had Covid and has had two doses of the vaccine, will have 90 percent protection against the virus for an additional year. According to the research, the best strategy to guard against future Covid infection is to …

Why are so many vaccinated people getting COVID-19 lately?
2 years, 11 months ago

Why are so many vaccinated people getting COVID-19 lately?

Associated Press  

Why are so many vaccinated people getting COVID-19 lately? Omicron is more likely to infect people, even if it doesn’t make them very sick, and its surge coincided with the holiday travel season in many places. People might mistakenly think the COVID-19 vaccines will completely block infection, but the shots are mainly designed to prevent severe illness, says Louis Mansky, …

New COVID studies show promise for the Johnson & Johnson vaccine booster
2 years, 11 months ago

New COVID studies show promise for the Johnson & Johnson vaccine booster

NPR  

New COVID studies show promise for the Johnson & Johnson vaccine booster Enlarge this image toggle caption Rajesh Jantilal/AFP via Getty Images Rajesh Jantilal/AFP via Getty Images Two new studies of a Johnson & Johnson COVID-19 vaccine booster showed promise against the omicron variant at a time when public health officials are urgently recommending booster shots against the fast-spreading variant. …

The big vaccine pivot: Merck falters on Covid-19 shots, then makes one for rival
3 years ago

The big vaccine pivot: Merck falters on Covid-19 shots, then makes one for rival

Live Mint  

Weeks after Merck & Co. scrapped development of its Covid-19 vaccines in January, one of its senior manufacturing officials began phoning his deputies, telling them their work on a pandemic shot wasn’t actually over. J&J’s unusual collaboration with a rival, and Merck’s speedy manufacturing run-up, reflect one of the biggest challenges of the pandemic: making enough Covid-19 vaccines to meet …

Pfizer says COVID booster ‘effective’ against Omicron variant
3 years ago

Pfizer says COVID booster ‘effective’ against Omicron variant

Al Jazeera  

Lab tests show the three-shot course of Pfizer-BioNTech vaccine neutralises Omicron, while two shots appear less effective. Pfizer has said a booster dose of its COVID-19 vaccine was able to neutralise the new Omicron variant in lab studies, even though the initial two doses appear significantly less effective. According to the early laboratory research using blood serum from vaccinated people, …

J&J Covid vaccine booster raised immune response after Pfizer vaccine, study finds
3 years ago

J&J Covid vaccine booster raised immune response after Pfizer vaccine, study finds

CNN  

CNN — Using the Johnson & Johnson vaccine as a booster for people initially immunized with the Pfizer/BioNTech vaccine produces a strong immune response and may do more to elicit protection against severe disease, researchers reported Sunday. Their small study of 65 volunteers who all initially got two doses of Pfizer/BioNTech’s vaccine showed that using the J&J Janssen vaccine as …

Protection offered by booster shot beats ‘natural immunity,’ study suggests
3 years ago

Protection offered by booster shot beats ‘natural immunity,’ study suggests

LA Times  

Michael Stremfel prepares a COVID-19 booster shot at Flintridge Pharmacy in La Cañada Flintridge. A new study finds that people who got a booster shot generated much higher levels of neutralizing antibodies than people who had a coronavirus infection. A small study that’s among the first to track people’s protective antibodies over time found that those who were immunized against …

Johnson & Johnson's COVID-19 vaccine is 74% effective at preventing infection, study finds
3 years, 1 month ago

Johnson & Johnson's COVID-19 vaccine is 74% effective at preventing infection, study finds

Daily Mail  

Johnson & Johnson's COVID-19 vaccine is more than 70 percent effective at preventing infection, a new study finds. However, despite the effectiveness, the team still recommend people to get the Pfizer or Moderna vaccines if possible Researchers found that 0.7% of people vaccinated with the J&J vaccine contracted Covid during the study period, compared to 2.5% of unvaccinated people After …

British PM Boris Johnson rules out another lockdown amid rising Covid-19 infections
3 years, 2 months ago

British PM Boris Johnson rules out another lockdown amid rising Covid-19 infections

India Today  

British Prime Minister Boris Johnson insisted on Friday that the country’s rising Covid-19 infections daily figure, which crossed 50,000 this week, is “fully in line” with predictions and ruled out the need for another national lockdown. The National Health Service said Covid booster jabs have now been delivered or booked in at almost nine in 10 care homes as the …

Pfizer-BioNTech report high efficacy of COVID boosters in study
3 years, 2 months ago

Pfizer-BioNTech report high efficacy of COVID boosters in study

Al Jazeera  

The companies say phase III trial data show booster shot of COVID-19 vaccine was 95.6 percent effective against the disease. American pharmaceutical company Pfizer and its partner BioNTech have said data from a Phase III trial demonstrated high efficacy of a booster dose of their COVID-19 vaccine against the coronavirus, including the Delta variant. They said a trial of 10,000 …

FDA authorizes booster doses of Moderna and Johnson & Johnson vaccines, says mix and match OK
3 years, 2 months ago

FDA authorizes booster doses of Moderna and Johnson & Johnson vaccines, says mix and match OK

CNN  

CNN — The US Food and Drug Administration authorized booster doses of Covid-19 vaccines made by Moderna and Johnson & Johnson Wednesday and also said any of the three authorized vaccines could be used as a booster in a “mix and match” approach. The FDA gave emergency use authorization for a half dose of Moderna’s vaccine as a booster for …

Month On, Johnson & Johnson’s Covid Vaccines Stuck at Kasauli Lab Over Pending Data from Indian Maker
3 years, 2 months ago

Month On, Johnson & Johnson’s Covid Vaccines Stuck at Kasauli Lab Over Pending Data from Indian Maker

News 18  

American pharma giant Johnson & Johnson’s Covid-19 vaccine shots, manufactured in India by Hyderabad-based Biological E, are stuck at the country’s apex vaccine testing laboratory in Himachal Pradesh due to pending data, News18.com has learnt. The batch of around 35 lakh vaccine doses, which arrived at the Central Drugs Laboratory in Kasauli over a month ago, are lying at the …

FDA panel endorses booster shot for J&J COVID-19 vaccine
3 years, 2 months ago

FDA panel endorses booster shot for J&J COVID-19 vaccine

The Hindu  

U.S. health advisors endorsed a booster of Johnson & Johnson’s COVID-19 vaccine on Friday, citing concern that Americans who got the single-dose shot aren’t as protected as those given two-dose brands. Unable to settle the best timing, the FDA’s advisory panel voted unanimously that the booster should be offered at least two months after people got their earlier shot. “It …

J&J vaccine recipients should get their second dose as soon as it’s available, experts say
3 years, 2 months ago

J&J vaccine recipients should get their second dose as soon as it’s available, experts say

CNN  

CNN — As the greenlight looms for another dose of Johnson & Johnson’s Covid-19 vaccine, experts on Friday urged those who received it to get a booster shot as soon as it’s available because it will provide them with the best protection against the coronavirus. The US Food and Drug Administration advisory committee recommended Friday that all adults who received …

FDA advisers recommend J&J Covid-19 vaccine boosters, talk mix and match boosters
3 years, 2 months ago

FDA advisers recommend J&J Covid-19 vaccine boosters, talk mix and match boosters

CNN  

CNN — Vaccine advisers to the US Food and Drug Administration voted unanimously Friday to recommend a booster dose of Johnson & Johnson’s vaccine at least two months after people get the first dose. The FDA’s Vaccines and Related Biological Products Advisory Committee voted 19-0 to recommend the extra dose for all recipients of the J&J Janssen vaccine, which is …

People who got Janssen vaccine should get mRNA booster, study suggests
3 years, 2 months ago

People who got Janssen vaccine should get mRNA booster, study suggests

NL Times  

Americans vaccinated with the Janssen vaccine have a much stronger immune response to Covid-19 after a booster shot with an mRNA vaccine from Moderna or Pfizer/BioNTech than after a booster with Janssen. All 450 participants had a stronger immune response two weeks after the booster shot, but that effect was the greatest in people who originally received Janssen and then …

US coronavirus: With more Covid-19 booster shots on the horizon, one expert says mixing and matching doses may be an effective approach
3 years, 2 months ago

US coronavirus: With more Covid-19 booster shots on the horizon, one expert says mixing and matching doses may be an effective approach

CNN  

CNN — Amid the growing prospect of more Covid-19 booster shots becoming available, an expert has suggested that some people could receive a dose of a different vaccine from the one they initially received. “I hope that when the FDA and CDC review data around Moderna and Johnson & Johnson that they will allow a mix-and-match approach,” CNN medical analyst …

Pfizer vaccine highly effective against Covid hospitalisations for six months: Study
3 years, 2 months ago

Pfizer vaccine highly effective against Covid hospitalisations for six months: Study

Deccan Chronicle  

Washington: Two doses of the Pfizer COVID-19 vaccine are 90 per cent effective against hospitalisation from the disease for all variants, including Delta, for at least six months, according to a study published in The Lancet journal on Tuesday. The researchers found that over the study period, effectiveness of the vaccine against all SARS-COV-2 infections declined, falling from 88 per …

Vaccine protection against Covid-19 wanes over time, especially for older people, CDC says
3 years, 3 months ago

Vaccine protection against Covid-19 wanes over time, especially for older people, CDC says

CNN  

CNN — The protection provided by Covid-19 vaccines appears to wane over time, especially for people 65 and older, a US Centers for Disease Control and Prevention expert said Wednesday. The conversation for now is focused on a third dose – a booster – of the company’s two-dose Covid-19 vaccine, and experience with past vaccines suggests a third dose may …

J&J Says Booster Shot Increases Protection to 94% for Moderate-Severe Covid-19
3 years, 3 months ago

J&J Says Booster Shot Increases Protection to 94% for Moderate-Severe Covid-19

News 18  

Johnson & Johnson said Tuesday a second shot of its COVID-19 vaccine given about two months after the first increased its effectiveness to 94% in the United States against moderate to severe forms of the disease. President Joe Biden is pushing for booster shots in the face of surging hospitalizations caused by the Delta variant and J&J, the only drugmaker …

Two dose version of Johnson & Johnson shot 94% effective against Covid-19, study finds
3 years, 3 months ago

Two dose version of Johnson & Johnson shot 94% effective against Covid-19, study finds

CNN  

CNN — A two-dose version of Johnson & Johnson’s coronavirus vaccine provides 94% protection against symptomatic infection, the company said Tuesday – making a two-dose regimen of J&J’s Janssen vaccine comparable to a two-dose regimen of Moderna’s or Pfizer’s. “Our large real-world-evidence and Phase 3 studies confirm that the single-shot Johnson & Johnson vaccine provides strong and long-lasting protection against …

Made by Biological E, J&J's Single-Shot Covid Vaccine to Hit Market Next Month
3 years, 3 months ago

Made by Biological E, J&J's Single-Shot Covid Vaccine to Hit Market Next Month

News 18  

US Pharma giant Johnson & Johnson’s single shot vaccine manufactured by Hyderabad-based Biological E is likely to be rolled out by October, News18.com has learnt. The vaccine batches are expected to go for the final testing at the apex laboratories — Central Drugs Laboratory, Kasauli and National Centre for Cell Science, Pune — by next week. “The vaccine is likely …

Vaccine booster shot holdup: Some may miss the Sept. 20 start
3 years, 3 months ago

Vaccine booster shot holdup: Some may miss the Sept. 20 start

LA Times  

President Biden’s plans to start delivery of booster shots by Sept. 20 for most Americans who received the COVID-19 vaccines are facing new complications that could delay the availability of third doses for those who received the Moderna vaccine, administration officials said Friday. Dr. Janet Woodcock, the acting FDA commissioner, and CDC Director Dr. Rochelle Walensky, briefed White House COVID-19 …

Trials for Johnson & Johnson HIV vaccine FAIL as shots were determined to be only 25% effective
3 years, 3 months ago

Trials for Johnson & Johnson HIV vaccine FAIL as shots were determined to be only 25% effective

Daily Mail  

Trials for Johnson & Johnson's HIV vaccine have failed to demonstrate that the drug is effective in preventing the condition. Johnson & Johnson's trial for a HIV vaccine was deemed to have failed, after the shots only showed 25% effectiveness in preventing the virus. Pictured: A National Institutes of Health handout of a white blood cell infected with HIV 'While …

J&J Says A Booster Shot For Its Vaccine May Have Big Benefits
3 years, 4 months ago

J&J Says A Booster Shot For Its Vaccine May Have Big Benefits

NPR  

J&J Says A Booster Shot For Its Vaccine May Have Big Benefits Enlarge this image toggle caption Robyn Beck/AFP via Getty Images Robyn Beck/AFP via Getty Images Johnson & Johnson says it has evidence that people who received its one-shot COVID-19 vaccine could benefit from a booster shot after six months. Sponsor Message "We have established that a single shot …

Johnson & Johnson files application to test its COVID vaccine on adolescents; all you need to know
3 years, 4 months ago

Johnson & Johnson files application to test its COVID vaccine on adolescents; all you need to know

Firstpost  

The US-based pharmaceutical company noted that it is committed to facilitating global equitable access to its COVID-19 vaccine and recognise the unmet needs of children Johnson & Johnson Friday said it has submitted an application to the Indian drug regulator to conduct a study of its COVID-19 vaccine in adolescents aged 12-17 years. The US-based pharmaceutical company noted that it …

Johnson and Johnson seeks nod for vaccine trials on 12-17 age group
3 years, 4 months ago

Johnson and Johnson seeks nod for vaccine trials on 12-17 age group

The Hindu  

U.S. pharma major Johnson & Johnson has applied for permission to conduct clinical trials of its single-shot COVID-19 vaccine on adolescents aged 12-17 years in India. J&J India spokesperson in a statement said: “We are committed to facilitating global equitable access to its COVID-19 vaccine and recognise the unmet needs of children. On August 17, 2021, we submitted an application …

J&J Applies for Covid-19 Vaccine Study in Indian Adolescents
3 years, 4 months ago

J&J Applies for Covid-19 Vaccine Study in Indian Adolescents

News 18  

Johnson & Johnson on Friday said it has submitted an application to the Indian drug regulator to conduct a study of its COVID-19 vaccine in adolescents aged 12-17 years. “On August 17, 2021, we submitted an application to the Central Drugs Standard Control Organisation to conduct a study of the Johnson & Johnson COVID-19 vaccine in India in adolescents aged …

US health officials call for booster shots against COVID-19
3 years, 4 months ago

US health officials call for booster shots against COVID-19

Associated Press  

WASHINGTON — U.S. health officials Wednesday announced plans to dispense COVID-19 booster shots to all Americans to shore up their protection amid the surging delta variant and signs that the vaccines’ effectiveness is slipping. Dr. Anthony Fauci, the government’s foremost expert on COVID-19, said one of the key lessons of the coronavirus is that it’s better to “stay ahead of …

US calls for booster shots against Covid Delta variant
3 years, 4 months ago

US calls for booster shots against Covid Delta variant

India TV News  

U.S. health officials Wednesday recommended all Americans get COVID-19 booster shots to shore up their protection amid the surging delta variant and evidence that the vaccines' effectiveness is falling. The plan, as outlined by the director of the Centers for Disease Control and Prevention and other top authorities, calls for an extra dose eight months after people get their second …

Single vaccine dose gives little protection against Covid infections, finds hospital study
3 years, 4 months ago

Single vaccine dose gives little protection against Covid infections, finds hospital study

India Today  

A study conducted by the Ganga Ram Hospital in Delhi has found that a single vaccine dose offered no protection against symptomatic Covid-19 cases during the Delta variant surge. The Sir Ganga Ram Hospital in New Delhi has stated the study covered some of the hospital staff, 2716 of whom had received both doses and 623 had received a single …

US health officials call for booster shots against COVID-19
3 years, 4 months ago

US health officials call for booster shots against COVID-19

Al Jazeera  

Surging Delta variant and evidence that the vaccines’ effectiveness fades after eight months drive call for boosters. US health officials are recommending that all Americans get COVID-19 booster jabs to shore up their protection amid the surging delta variant and evidence that the vaccines’ effectiveness is falling. “This is likely due to both waning immunity, and the strength of the …

CDC recommends extra Covid-19 vaccine dose for certain immunocompromised people
3 years, 4 months ago

CDC recommends extra Covid-19 vaccine dose for certain immunocompromised people

CNN  

CNN — Vaccine advisers to the US Centers for Disease Control and Prevention voted unanimously on Friday to recommend an extra dose of Covid-19 vaccine for some immunocompromised people, and the CDC director signed off on the recommendation almost immediately. So far, “approximately, 140 million individuals completed a two-dose primary series of either Moderna or Pfizer/BioNTech Covid-19 vaccine,” Dr. Kathleen …

News18 Evening Digest: Johnson & Johnson's Single-Dose Covid-19 Vaccine Gets Approval in India and Other Top Stories
3 years, 4 months ago

News18 Evening Digest: Johnson & Johnson's Single-Dose Covid-19 Vaccine Gets Approval in India and Other Top Stories

News 18  

Johnson & Johnson?s Jab Added to List: India Now Has 5 Vaccines for Adults, All You Need to Know Johnson and Johnson?s single-dose Covid-19 vaccine has been given approval for emergency use in India. 50 People Arrested, Over 150 Booked in Pakistan for Attack on Hindu Temple Pakistan’s law enforcement agencies on Saturday arrested over 50 people, including the main …

Is J&J Vaccine Effective Against Delta Variant? This African Study Answers in Affirmative
3 years, 4 months ago

Is J&J Vaccine Effective Against Delta Variant? This African Study Answers in Affirmative

News 18  

Data from a clinical trial in South Africa suggests that a single dose of the Covid-19 vaccine made by Johnson & Johnson is highly effective in preventing severe illness and death from the Delta and Beta variants of the coronavirus. As per media reports, the trial evaluated one dose of the Johnson & Johnson vaccine in nearly 500,000 health care …

Johnson & Johnson's single-dose COVID-19 vaccine gets Emergency Use approval in India for adult population
3 years, 4 months ago

Johnson & Johnson's single-dose COVID-19 vaccine gets Emergency Use approval in India for adult population

Firstpost  

J&J earlier had sought approval to conduct phase-3 clinical trial of its vaccine on approximately 600 participants in two age groups—those aged 18 and below 60 years and those aged 60 years and above—to evaluate the safety, reactogenicity and immunogenicity of the jab in healthy Indian adults. Johnson & Johnson’s single-dose COVID-19 vaccine has been given Emergency Use approval in …

Wary of ‘breakthrough’ infections, some vaccinated people eye another shot. Is it needed?
3 years, 4 months ago

Wary of ‘breakthrough’ infections, some vaccinated people eye another shot. Is it needed?

LA Times  

A health official prepares a COVID-19 vaccine to give to seniors during a vaccination clinic in Lakewood on March 31. Dr. Naveena Bobba, San Francisco’s acting health officer, said the decision followed requests from some residents who were hoping another shot would afford them additional protection. The difference between getting COVID-19 while vaccinated could be the sniffles versus suffocation if …

Johnson & Johnson Applies for Emergency Approval of Its Single-dose Covid Vaccine in India
3 years, 4 months ago

Johnson & Johnson Applies for Emergency Approval of Its Single-dose Covid Vaccine in India

News 18  

Global healthcare major Johnson & Johnson on Friday said it has applied for Emergency Use Authorization of its single-dose COVID-19 vaccine in India. Earlier on Monday, the company had said that it remained committed to bringing its single-dose COVID-19 vaccine to India and looks forward to ongoing discussions with the Indian government. "On August 5, 2021 Johnson & Johnson Pvt …

Johnson & Johnson applies for approval of its single-dose Covid-19 vaccine in India
3 years, 4 months ago

Johnson & Johnson applies for approval of its single-dose Covid-19 vaccine in India

India TV News  

Global healthcare major Johnson & Johnson on Friday said it has applied for Emergency Use Authorization of its single-dose COVID-19 vaccine in India. Earlier on Monday, the company had said that it remained committed to bringing its single-dose COVID-19 vaccine to India and looks forward to ongoing discussions with the Indian government. "On August 5, 2021 Johnson & Johnson Pvt …

Discover Related